Stay updated with breaking news from Barry shulkin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
During its 2023 Annual Meeting, held June 24-27 in Chicago, the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI named Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at Stanford (CA), and clinical professor of radiology at the Stanford School of Medicine, as its President, introduced its new slate of officers and recognized 10 new fellows.
St. Jude Children’s Research Hospital phase II clinical trial results suggest that the monoclonal antibody hu14.18K322A could help change treatment of....
Excellent outcomes reported for first targeted therapy for pediatric Hodgkin lymphoma eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Date Time Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma (From left) First and corresponding author Monika Metzger, M.D., Departments of Oncology and Global Pediatric Medicine; co- senior author Matthew Krasin, M.D., Department of Radiation Oncology; and co-senior author Melissa Hudson, M.D., Cancer Survivorship Division director. Scientists are reporting results of the first frontline clinical trial to use targeted therapy to treat high-risk pediatric Hodgkin lymphoma. The study showed that the addition of brentuximab vedotin achieved excellent outcomes, reduced side effects, and allowed for reduced radiation exposures. The study was the result of work by a multi-site consortium dedicated to pediatric Hodgkin-lymphoma. Collaborating institutions include St. Jude Children’s Research Hospital, Stanford University School of Medicine, Dana-Farber Cancer Institute, Massachusetts General Hospital, Maine Children’s Cancer Program and OSF Children’s Hospital of Illinois.